Acadia up again last night off the back of top line positive results in Trof/Rhett phase 3 trial just owing US rights and having to pay us royalties and milestones!
Yesterday was a big day for us with share price appreciation that was well overdue here, we doubled our market cap to $400m, however Acadia put on $1B added to their market cap.
What will today bring, will we nudge our previous highs in 2015 & 2018 of $3.60 when were were expecting a Pharma deal TBC.
We have phase 3 successful top line results now, 65% chance at phase 2 Nz-2591 seriously de risked now!
Can we start to see share price appreciation to reflect analyst valuations anything like recent Evans Partners $5.40 pre results to $7.70 after positive results?
Not that I think we would except a TO offer here given we are considerably de risked, but any serious offers now would be starting at $1B for Neu?
NEU Price at posting:
$3.25 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)